Revolutionizing Therapeutics: The Evolution Of Monoclonal Antibodies
Technological advancements have enhanced monoclonal antibody development, production, and application, creating more effective, personalized, and safer treatments. Monoclonal antibodies (mAbs) have revolutionized therapeutics and diagnostics, particularly in cancer treatment, autoimmune diseases, and infectious diseases. These antibodies, produced from a single clone of immune cells, are engineered to target specific antigens with precision.